Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Revenue

In the year 2025, Aprea Therapeutics had annual revenue of $285.76K, down -80.98%. Aprea Therapeutics had revenue of $3.34K in the quarter ending December 31, 2025, a decrease of -98.38%.

• Revenue (ttm): $285.76K
• Revenue Growth: -80.98%
• P/S Ratio: 33.79
• Revenue / Employee: $35,720
• Employees: 8
• Market Cap: 9.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	285.76K	-1.22M	-80.98%
Dec 31, 2024	1.50M	919.35K	157.63%
Dec 31, 2023	583.23K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 6, 2026

Data Sources Report a data error